Bloomage BioTechnology Corporation Limited (688363.SS)
CNY 48.84
(0.93%)
CNY 48.84
(0.93%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 2.31 Million CNY | -98.56% |
| 2022 | 160.38 Million CNY | -25.03% |
| 2021 | 213.94 Million CNY | 356.12% |
| 2020 | 46.9 Million CNY | 0.0% |
| 2019 | - CNY | -100.0% |
| 2018 | 1.00 CNY | 0.0% |
| 2017 | 1.00 CNY | 0.0% |
| 2016 | - CNY | -100.0% |
| 2015 | 366.87 Million CNY | 754.26% |
| 2014 | 42.94 Million CNY | -4.02% |
| 2013 | 44.74 Million CNY | -1.85% |
| 2012 | 45.58 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 92.85 Million CNY | 6130.78% |
| 2024 Q1 | 1.87 Million CNY | -18.91% |
| 2024 Q2 | 1.49 Million CNY | -20.64% |
| 2023 Q3 | 64.16 Million CNY | 30.07% |
| 2023 FY | 2.31 Million CNY | -98.56% |
| 2023 Q2 | 49.32 Million CNY | 18.64% |
| 2023 Q1 | 41.58 Million CNY | -74.08% |
| 2023 Q4 | 2.31 Million CNY | -96.39% |
| 2022 Q3 | 150.81 Million CNY | -4.6% |
| 2022 Q2 | 158.08 Million CNY | -13.92% |
| 2022 Q1 | 183.64 Million CNY | -14.17% |
| 2022 FY | 160.38 Million CNY | -25.03% |
| 2022 Q4 | 160.38 Million CNY | 6.35% |
| 2021 Q1 | 217.12 Million CNY | 362.9% |
| 2021 Q3 | 216.08 Million CNY | 6.11% |
| 2021 Q4 | 213.94 Million CNY | -0.99% |
| 2021 FY | 213.94 Million CNY | 356.12% |
| 2021 Q2 | 203.64 Million CNY | -6.21% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 FY | 46.9 Million CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q4 | 46.9 Million CNY | 0.0% |
| 2019 FY | - CNY | -100.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | 1.00 CNY | 0.0% |
| 2018 Q4 | 1.00 CNY | 0.0% |
| 2017 Q1 | 613.09 Million CNY | 16.73% |
| 2017 Q2 | 613.09 Million CNY | 0.0% |
| 2017 FY | 1.00 CNY | 0.0% |
| 2016 Q2 | 370.31 Million CNY | 0.0% |
| 2016 Q4 | 525.2 Million CNY | 0.0% |
| 2016 Q3 | 525.2 Million CNY | 41.83% |
| 2016 Q1 | 370.31 Million CNY | 0.94% |
| 2016 FY | - CNY | -100.0% |
| 2015 Q2 | 35.63 Million CNY | 0.0% |
| 2015 Q3 | 366.87 Million CNY | 929.52% |
| 2015 Q4 | 366.87 Million CNY | 0.0% |
| 2015 Q1 | 35.63 Million CNY | -17.02% |
| 2015 FY | 366.87 Million CNY | 754.26% |
| 2014 FY | 42.94 Million CNY | -4.02% |
| 2014 Q3 | 42.94 Million CNY | 11.64% |
| 2014 Q1 | 38.46 Million CNY | -14.03% |
| 2014 Q2 | 38.46 Million CNY | 0.0% |
| 2014 Q4 | 42.94 Million CNY | 0.0% |
| 2013 FY | 44.74 Million CNY | -1.85% |
| 2013 Q2 | 40.18 Million CNY | 0.0% |
| 2013 Q1 | 40.18 Million CNY | -11.85% |
| 2013 Q4 | 44.74 Million CNY | 0.0% |
| 2013 Q3 | 44.74 Million CNY | 11.35% |
| 2012 FY | 45.58 Million CNY | 0.0% |
| 2012 Q4 | 45.58 Million CNY | 0.0% |
| 2012 Q3 | 45.58 Million CNY | 0.0% |